Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 50Active not recruiting 7Withdrawn 4Recruiting 4Unknown 3Terminated 3No longer available 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Advanced Prostate Cancer 1

Interventions

Docetaxel 33Radiosurgery 23Radiotherapy 21Sunitinib 20pembrolizumab 18Gemcitabine 16Cisplatin 16Androgen Antagonists 15Nivolumab 14enzalutamide 13Goserelin 13Prednisone 12Leuprolide 12Blood Specimen Collection 12Abiraterone Acetate 12bicalutamide 11aldesleukin 11Surveys and Questionnaires 11Cyclophosphamide 11Gonadotropin-Releasing Hormone 10Bevacizumab 10Multiparametric Magnetic Resonance Imaging 9Carboplatin 9acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 8Triptorelin Pamoate 8Radiotherapy, Intensity-Modulated 8Filgrastim 8Epirubicin 8Chemotherapy, Adjuvant 8Brachytherapy 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × radium Ra 223 dichloride × Genitourinary × Clear all
NCT03458559 2020-11-17

RaRe

Amsterdam UMC, location VUmc

Phase 3 Unknown
402 enrolled
Genitourinary

Prostatic Neoplasms

NCT02925702 2020-01-27

PRORADIUM

Centro Nacional de Investigaciones Oncologicas CARLOS III

Unknown
161 enrolled
Genitourinary

Advanced Prostate Cancer

NCT02484339 2016-04-27

α-RT

University Hospital Freiburg

Phase 2 Unknown
274 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡